Skip to content

GE HealthCare Technologies GEHC Additional Paid-In Capital

Additional Paid-In Capital at other companies

iRadimed logo
iRadimedIRMD
$31.02M+0.9%
HTF
Heartflow, Inc. Common StockHTFL
$1.4B
Lantheus Holdings logo
Lantheus HoldingsLNTH
$892.95M+8.7%
Butterfly Network logo
Butterfly NetworkBFLY
$1.08B+2.6%
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
$60.23M+163%
RadNet logo
RadNetRDNT
$1.21B+19.2%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.12B-15.1%
P/E15.2×-0.1×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's additional paid-in capital?
GE HealthCare Technologies (GEHC) reported additional paid-in capital of $6.73B in Q1 2026.
How has GE HealthCare Technologies's additional paid-in capital changed year-over-year?
GE HealthCare Technologies's additional paid-in capital increased by 2.1% year-over-year, from $6.6B to $6.73B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.